GALT Galectin Therapeutics Inc. logo

GALT Galectin Therapeutics Inc.

Healthcare
$2.79+11.60%ClosedMarket Cap: $183.7M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

3

Dispositions

12

Buy/Sell Ratio

0.25

Net Shares

-204,000

Shares Acquired

204,000

Shares Disposed

408,000

Total Bought ($)

$0.00

Total Sold ($)

$9.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 17Brem HenrydirectorSell60,000$3.1660,000
Tue Mar 17Brem HenrydirectorSell0$0.000
Mon Feb 09ELDRED KARYdirectorBuy300$2.7065,682
Thu Jan 22LEWIS JOELdirector, officer: President and CEOSell91,000$3.0491,000
Wed Jan 21Zordani Richard A. Jr.directorSell60,000$3.0460,000
Wed Jan 21Jamil Khurramofficer: Chief Medical OfficerSell100,000$0.00100,000
Wed Jan 21Jamil Khurramofficer: Chief Medical OfficerSell65,000$3.0465,000
Wed Jan 21FREEMAN KEVIN DdirectorSell60,000$3.0460,000
Wed Jan 21ELDRED KARYdirectorSell60,000$3.0460,000
Wed Jan 21CARSON BENJAMIN SRdirectorSell60,000$3.0460,000